Topiramate in the prophylactic treatment of cluster headache

Headache

Volumn 43, Issue 7, 2003, Pages 784-789

  Láinez, Miguel J A ^a   Pascual, Julio ^b   Pascual, Ana M ^b   Santonja, Jose M ^a   Ponz, Alejandro ^a   Salvador, Antonio ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE

Author keywords

Clinical trials; Cluster headache; Preventive treatment; Topiramate

Indexed keywords

4 AMINOBUTYRIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; DIPYRONE; ERGOTAMINE; LITHIUM; METHYLPREDNISOLONE; NADOLOL; PREDNISONE; SUMATRIPTAN; TOPIRAMATE; VALPROATE SEMISODIUM; VERAPAMIL; ZOLMITRIPTAN;

ADULT; AGED; ARTICLE; ATAXIA; BLOOD TOXICITY; CHRONIC DISEASE; CLINICAL ARTICLE; CLUSTER HEADACHE; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG TOLERABILITY; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER TOXICITY; MEMORY DISORDER; NEUROLOGIC DISEASE; PARESTHESIA; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; REMISSION; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; TREATMENT FAILURE; VERTIGO; WEIGHT REDUCTION;

ADULT; AGED; ANTICONVULSANTS; CHRONIC DISEASE; CLUSTER HEADACHE; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0041526984     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03137.x     Document Type: Article

References (26)

1. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology. 2002;58:354-361.
2. Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Cluster headache. Cephalalgia. 2000;20:787-803.
3. Goadsby PJ, Bahra A, May A. Mechanisms of cluster headache. Cephalalgia. 1999;19(suppl 23):19-21.
4. Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain. 2002;125:976-984.
5. Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep. 2001;5:83-91.
6. Leone M, D'Amico D, Mos Chiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia. 1996;16:494-496.
7. Speight TM, Avery GS. Pizotifen: a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Am J Med Sci. 1972;240:327-331.
8. Marks DR, Rapoport A, Padla D. A double-blind placebo-controlled trial of intra-nasal capsaicin for cluster headache. Cephalalgia. 1993;13:114-116.
9. Caviness VS, O'Brien P. Cluster headache: response to chlorpromazine. Headache. 1980;20:128-131.
10. Kudrow L, Esperanca P, Vijayan N. Episodic paroxysmal hemicrania? Cephalalgia. 1987;7:197-201.
11. Meyer JS, Hardenberg J. Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headache. Headache. 1990;30:411-417.
12. Tay BA, Ngan Kee WD, Chung DC. Gabapentin for the treatment and prophylaxis of cluster headache. Reg Anesth Pain Med. 2001;26:373-375.
13. Wheeler SD, Carrazana MD. Topiramate-treated cluster headache. Neurology. 1999;53:234.
14. Sombati S, Coulter DA, De Lorenzo RJ. Effects of topiramate on sustained repetitive firing and low Mg 2+-induced seizure discharges in cultured hippocampal neurons. Epilepsia. 1995;36(suppl 4):38.
15. Stephen LJ, Sills GJ, Brodie MJ. Topiramate in refractory epilepsy: a prospective observational study. Epilepsia. 2000;41:977-980.
16. Abou-Khalil B. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group. Epilepsia. 2000;4141:S72-S76.
17. Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology. 1996;46:1684-1690.
18. Fariello RG, Varasi M, Smith MC. Valproic acid: mechanism of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs. New York, NY: Raven Press, Ldt; 1995:581-588.
19. Wheeler SD. Significance of migrainous features in cluster headache: divalproex responsiveness. Headache. 1998;38:547-551.
20. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia. 1989;9:195-198.
21. Kuzniecky R, Hetherington H, Ho S. Topiramate increases cerebral GABA in healthy humans. Neurology. 1998;51:627-629.
22. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 1997;28:167-179.
23. Cruczwar SJ, Patsalos PN. New generation of GABA enchancers. Potential in the treatment of epilepsy. CNS Drugs. 2001;15:339-350.
24. Petroff OA, Hyder F, Rothman DL, Mattson RH. Human brain GABA and homocarnosine increased after starting topiramate [abstract]. Neurology. 1998;50(suppl 4):A312.
25. Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic and clinical data. Clin Ther. 1997;19:1294-1308.
26. Bourgeois BF. Pharmacokinetics and pharmacodynamics of topiramate. J Child Neurol. 2000;15(suppl 1):S27-S30.